NCT01056874View on ClinicalTrials.gov

Effect Of Maraviroc On The Pharmacokinetics Of Digoxin

PHASE1CompletedINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

April 30, 2010

Study Completion Date

April 30, 2010

Conditions

HealthyHIV Infections

Interventions

DRUG

Digoxin

Oral Digoxin 0.25 mg single dose

DRUG

Digoxin

Oral Digoxin 0.25 mg single dose on Day 5

DRUG

Maraviroc

Oral Maraviroc 300 mg twice daily for 6 days

Trial Locations (1)

188770

Pfizer Investigational Site, Singapore

Sponsors

Lead Sponsor

ViiV Healthcare

Collaborators (1)

All Listed Sponsors

collaborator

Pfizer

INDUSTRY

lead

ViiV Healthcare

INDUSTRY